Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

PHAROS

K-Number: K250170 · 2025-08-15

Decision Date2025-08-15
Product CodeKPS
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

PHAROS is the device name listed in this FDA 510(k) record. The listed applicant is Brightonix Imaging. It received FDA 510(k) clearance on 2025-08-15 under 510(k) number K250170. The device is classified under product code KPS. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the PHAROS?

PHAROS is a medical device that received FDA 510(k) clearance on 2025-08-15. The listed applicant is Brightonix Imaging. The 510(k) number is K250170.

When did PHAROS receive FDA 510(k) clearance?

PHAROS received FDA 510(k) clearance on 2025-08-15, under 510(k) number K250170.

Who is the listed applicant for PHAROS?

The FDA 510(k) record lists Brightonix Imaging as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for PHAROS?

The FDA product code for PHAROS is KPS.

Related Devices (Code: KPS)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.